FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
-0.25%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$19.7B
AUM Growth
-$819M
(-4%)
Cap. Flow
-$166M
Cap. Flow
% of AUM
-0.84%
Top 10 Holdings %
Top 10 Hldgs %
34.79%
Holding
645
New
74
Increased
167
Reduced
252
Closed
94
Top Buys
| 1 |
PARA
Paramount Global Class B
PARA
|
$249M |
| 2 |
Honeywell
HON
|
$222M |
| 3 |
Newell Brands
NWL
|
$179M |
| 4 |
AT&T
T
|
$153M |
| 5 |
Apple
AAPL
|
$148M |
Top Sells
| 1 |
Amazon
AMZN
|
$195M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
$184M |
| 3 |
Yum! Brands
YUM
|
$161M |
| 4 |
Lowe's Companies
LOW
|
$159M |
| 5 |
Home Depot
HD
|
$115M |
Sector Composition
| 1 | Healthcare | 19.13% |
| 2 | Communication Services | 18.66% |
| 3 | Technology | 17.79% |
| 4 | Industrials | 12.35% |
| 5 | Consumer Discretionary | 11.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Darden Restaurants
DRI
$24.5B
| $992K | 0.01% |
14,963
-3,801
| -20% | -$252K |
|
377
Jazz Pharmaceuticals
JAZZ
$7.86B
| $982K | 0.01% |
7,522
-1,712
| -19% | -$224K |
|
|
ZAYO
378
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $959K | ﹤0.01% |
39,580
-42,013
| -51% | -$1.02M |
|
379
SAP
SAP
$313B
| $947K | ﹤0.01% |
11,780
| – | – |
|
380
Johnson Controls International
JCI
$69.5B
| $941K | ﹤0.01% |
23,054
-17,538
| -43% | -$716K |
|
381
Moody's
MCO
$89.5B
| $941K | ﹤0.01% |
9,748
-22,916
| -70% | -$2.21M |
|
382
Celldex Therapeutics
CLDX
$1.52B
| $927K | ﹤0.01% |
16,343
-6,362
| -28% | -$361K |
|
|
NFX
383
DELISTED
Newfield Exploration
NFX
| $924K | ﹤0.01% |
+27,782
| New | +$924K |
|
384
FedEx
FDX
$53.7B
| $897K | ﹤0.01% |
5,515
-69
| -1% | -$11.2K |
|
385
Amicus Therapeutics
FOLD
$2.46B
| $889K | ﹤0.01% |
105,150
-14,500
| -12% | -$123K |
|
|
HAR
386
DELISTED
Harman International Industries
HAR
| $861K | ﹤0.01% |
9,665
-28,716
| -75% | -$2.56M |
|
|
NVRO
387
DELISTED
NEVRO CORP.
NVRO
| $844K | ﹤0.01% |
15,000
-300
| -2% | -$16.9K |
|
388
Integra LifeSciences
IART
$1.25B
| $835K | ﹤0.01% |
24,800
+8,800
| +55% | +$296K |
|
|
STJ
389
DELISTED
St Jude Medical
STJ
| $829K | ﹤0.01% |
15,068
-11,850
| -44% | -$652K |
|
390
Garmin
GRMN
$45.7B
| $826K | ﹤0.01% |
20,666
| – | – |
|
391
Berkshire Hathaway Class B
BRK.B
$1.08T
| $809K | ﹤0.01% |
5,700
+700
| +14% | +$99.4K |
|
392
Duke Energy
DUK
$93.8B
| $802K | ﹤0.01% |
9,935
| – | – |
|
393
Merck
MRK
$212B
| $754K | ﹤0.01% |
14,934
| – | – |
|
394
Bruker
BRKR
$4.68B
| $741K | ﹤0.01% |
+26,450
| New | +$741K |
|
|
CEMP
395
DELISTED
Cempra, Inc.
CEMP
| $721K | ﹤0.01% |
41,150
-7,500
| -15% | -$131K |
|
|
CHMT
396
DELISTED
Chemtura Corporation
CHMT
| $719K | ﹤0.01% |
27,245
| – | – |
|
397
West Pharmaceutical
WST
$18B
| $700K | ﹤0.01% |
+10,100
| New | +$700K |
|
398
BorgWarner
BWA
$9.53B
| $699K | ﹤0.01% |
20,670
| – | – |
|
|
SCAI
399
DELISTED
Surgical Care Affiliates, Inc.
SCAI
| $650K | ﹤0.01% |
14,050
+500
| +4% | +$23.1K |
|
400
Novo Nordisk
NVO
$245B
| $639K | ﹤0.01% |
23,600
-48,800
| -67% | -$1.32M |
|